These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31649873)

  • 1. ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis.
    Chen L; Peng T; Luo Y; Zhou F; Wang G; Qian K; Xiao Y; Wang X
    Front Oncol; 2019; 9():957. PubMed ID: 31649873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis.
    Chen L; Yuan L; Qian K; Qian G; Zhu Y; Wu CL; Dan HC; Xiao Y; Wang X
    Front Physiol; 2018; 9():399. PubMed ID: 29720944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Expression Network Analysis Identified LTF in Association with Metastasis Risk and Prognosis in Clear Cell Renal Cell Carcinoma.
    Ni L; Yuan C; Zhang C; Xiang Y; Wu J; Wang X; Wu X
    Onco Targets Ther; 2020; 13():6975-6986. PubMed ID: 32764988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
    Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
    Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of
    Yang H; Wang Y; Zhang Z; Li H
    Front Genet; 2020; 11():905. PubMed ID: 32973873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
    Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
    J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC).
    Yuan L; Chen L; Qian K; Qian G; Wu CL; Wang X; Xiao Y
    Genom Data; 2017 Dec; 14():132-140. PubMed ID: 29159069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets.
    Naghdibadi M; Momeni M; Yavari P; Gholaminejad A; Roointan A
    Kidney Blood Press Res; 2023; 48(1):135-150. PubMed ID: 36854280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three novel hub genes and their clinical significance in clear cell renal cell carcinoma.
    Xiao H; Chen P; Zeng G; Xu D; Wang X; Zhang X
    J Cancer; 2019; 10(27):6779-6791. PubMed ID: 31839812
    [No Abstract]   [Full Text] [Related]  

  • 12. ACAT1 suppresses clear cell renal cell carcinoma progression by AMPK mediated fatty acid metabolism.
    Zheng M; Zhang S; Zhou J; Lin M; Liao Y
    Transl Oncol; 2024 Sep; 47():102043. PubMed ID: 38909457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis.
    Yuan L; Zeng G; Chen L; Wang G; Wang X; Cao X; Lu M; Liu X; Qian G; Xiao Y; Wang X
    Int J Biol Sci; 2018; 14(3):266-279. PubMed ID: 29559845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma.
    Zhang X; Wang Z; Zeng Z; Shen N; Wang B; Zhang Y; Shen H; Lu W; Wei R; Ma W; Wang C
    Cancer Cell Int; 2021 Apr; 21(1):222. PubMed ID: 33865387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying a Novel Biomarker
    Xiong Y; Yuan L; Chen L; Zhu Y; Zhang S; Liu X; Xiao Y; Wang X
    J Cancer; 2018; 9(21):3912-3922. PubMed ID: 30410595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression Network Analysis Identifies Fourteen Hub Genes Associated with Prognosis in Clear Cell Renal Cell Carcinoma.
    Chen JY; Sun Y; Qiao N; Ge YY; Li JH; Lin Y; Yao SL
    Curr Med Sci; 2020 Aug; 40(4):773-785. PubMed ID: 32862390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
    Peng Y; Greenland NY; Lang UE; Stohr BA
    Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma.
    Zhang H; Zou J; Yin Y; Zhang B; Hu Y; Wang J; Mu H
    PeerJ; 2019; 7():e8096. PubMed ID: 31788359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function.
    Zhang J; Wang Y; Ma J; Aimudula A
    Front Oncol; 2023; 13():1163714. PubMed ID: 37483501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
    Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
    Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.